Panel discussion: hormones and fetal metabolism.
D000305:Adrenal Cortex Hormones / Q000494:pharmacology; D004054:Diethylstilbestrol / Q000009:adverse effects; D005260:Female; D005333:Fetus / Q000378:metabolism*; D006728:Hormones / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology*; D006801:Humans; D006900:Hydroxylation; D007231:Infant, Newborn; D008168:Lung / Q000378:metabolism; D010634:Phenobarbital / Q000494:pharmacology; D010672:Phenytoin / Q000494:pharmacology; D010920:Placenta / Q000187:drug effects; D011247:Pregnancy; D011276:Pregnanediol / Q000494:pharmacology; D012127:Respiratory Distress Syndrome, Newborn / Q000517:prevention & control; D012725:Sexual Behavior / Q000187:drug effects; D013256:Steroids / Q000627:therapeutic use; D013501:Surface-Active Agents / Q000494:pharmacology
D000305:Adrenal Cortex Hormones; D006728:Hormones; D013256:Steroids; D013501:Surface-Active Agents; D010672:Phenytoin; D004054:Diethylstilbestrol; D011276:Pregnanediol; D010634:Phenobarbital